Strength
Premium growing double-digit
Net premium income grew 18.9% year on year (FY2025 → FY2026).
Importance 37 / 95 · growth
SBI Life Insurance Company Limited · Research view
SBI Life Insurance Company Limited
NSE: SBILIFEBSE: 540719ISIN INE123W01016Face value ₹10standalone
₹1,726
−0.39% · 2026-10-01 · 52-wk ₹1,653–₹2,110
Financials to FY2026 · 2 years of history · prices to 2026-10-01consolidatedstandalone
Section 02 · Synthesis
What stands out?
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
StrengthConcernWatchContext
Section 03 · The company
Who is this company?
Classified by the exchange under Financial Services › Financial Services › Insurance › Life Insurance.
- Market cap
- ₹1.73 L cr
- FY2026 net premium
- ₹99,956 cr
- FY2026 net profit
- ₹2,470 cr
- Net worth
- ₹19,086 cr
- Total assets
- ₹4,92,053 cr
- EPS (basic)
- ₹24.62
- Listed
- NSE · BSE
- Reporting
- IRDAIApr–Mar
Peer set used on this page: 4 life insurance.
Section 04 · Business performance
Is the business growing?
Net premiumNet profit
Strength
Net premium income grew 18.9% year on year (FY2025 → FY2026).
Rule INSURER_PREMIUM_GREW_YOY
- Net premium growth per year
- +18.9%over 1 years
- Net premium growth
- +18.9%vs last year
- Net profit growth
- +2.4%vs last year
- Change in net profit since FY25
- +2%
Section 05 · Recent activity
What changed recently?
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Strength
Q1 FY27 net profit was ₹725 cr, up 22.0% from ₹594 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Strength
Q1 FY27 net premium was ₹20,078 cr, up 16.9% from ₹17,178 cr in Q1 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Watch
Q1 FY27 claims ratio was 65.4%, up 6.48 percentage points from 58.9% a year earlier.
Rule QTR_INSURER_CLAIMS_RATIO_CHANGE_YOY
A. Quarterly results
Net premiumNet profit
| Quarter | Net premium | YoY | Net profit | YoY |
|---|---|---|---|---|
| Q4 FY25 | 23,861 | — | 814 | — |
| Q1 FY26 | 17,178 | — | 594 | — |
| Q2 FY26 | 24,848 | — | 495 | — |
| Q3 FY26 | 30,245 | — | 577 | — |
| Q4 FY26 | 27,684 | +16.0% | 805 | −1.1% |
| Q1 FY27 | 20,078 | +16.9% | 725 | +22.0% |
B. TTM snapshot
Trailing twelve months to 30 Jun 2026 · sum of the last 4 contiguous quarters
- Net premium
- ₹1,02,856 crTTM
- PBT
- ₹2,672 crTTM
- Net profit
- ₹2,601 crTTM
C. Corporate actions
6 Mar 2026DividendInterim Dividend - Rs. - 2.7000 — ₹2.70/share
7 Mar 2025DividendInterim Dividend - Rs. - 2.7000 — ₹2.70/share
15 Mar 2024DividendInterim Dividend - Rs. - 2.7000 — ₹2.70/share
16 Mar 2023DividendInterim Dividend - Rs. - 2.5000 — ₹2.50/share
29 Mar 2022DividendInterim Dividend - Rs. - 2.0000 — ₹2.00/share
5 Apr 2021DividendInterim Dividend - Rs. - 2.5000 — ₹2.50/share
3 Apr 2019DividendInterim Dividend - Rs. - 2.0000 — ₹2.00/share
3 Apr 2018DividendInterim Dividend - Rs. - 2.0000 — ₹2.00/share
Section 06 · Business performance
Is it becoming more profitable?
The metrics this section charts aren't mapped for this company's sector yet — see the data-coverage note in section 10.
- Net margin
- 2.2%
- Expense ratio
- 10.6%
- Benefits / premium
- 54.3%
- ROE FY2026
- 13.7%
Section 07 · Financial health
Is financial health improving?
Net worth (shareholders' funds)
Leverage and cash generation over the loaded history are shown above.
- Net worth
- ₹19,086 cr
- Total assets
- ₹4,92,053 cr
- Investments
- ₹4,86,367 cr
- Policyholders' surplus
- ₹3,289 cr
Section 08 · Relative position
How does it compare with peers?
Ranked against 4 life insurance (FY2026, consolidated). No peer-relative rule fired for this company.
Revenue growth
SBILIFE · 1st of 3 · set median 11.3%
Return on equity
SBILIFE · 2nd of 3 · set median 13.7%
P/E ratio
SBILIFE · 3rd of 4 · set median 62.4×
- P / E
- 66.6×TTM to Jun 26
- P / B
- 9.1×latest book
- P / S
- 1.7×TTM sales
- Earnings yield
- 1.5%TTM to Jun 26
On the trailing twelve months. Last full year: P/E 70.1× · P/S 1.5× · ROE 13.7%.
Section 09 · The stock
How has the stock performed?
Long-term price performance is shown above.
- 1-year return
- −4.2%
- 3-year return
- +32.2%
- 5-year return
- +42.8%
- From 52-wk high
- −18.2%
Section 10 · Technical data
What does the technical data say?
Price-action indicators as of 2026-10-01. Secondary to the fundamentals above — included for timing context, not as a signal.
- vs 50-day avg
- Below₹1,785
- vs 200-day avg
- Below₹1,885
- RSI (14)
- 45.2neutral
- MACD histogram
- 3.9
- From 52-wk high
- −18.2%
- From 52-wk low
- +4.4%
- 30-day volatility
- 22.3%ann.
- 6-month return
- −6.1%
Section 11 · Open questions
What should I investigate further?
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
Nothing is flagged for review for this company.
- Only 2 annual year(s) of financials loaded — multi-year trend analysis is limited.
Section 12 · Reference
The numbers
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY25 | FY26 |
|---|---|---|
| Revenue | 84,060 | 99,956 |
| Total income | 1,17,119 | 1,12,966 |
| Gross premium income | 84,985 | 1,01,286 |
| Net premium income | 84,060 | 99,956 |
| Benefits paid (net) | 48,902 | 54,323 |
| Profit before tax | 2,495 | 2,537 |
| Net profit | 2,413 | 2,470 |
| EPS (₹) | 24.1 | 24.6 |
| Net worth | 16,985 | 19,086 |
| Investments | 4,47,467 | 4,86,367 |
| Operating cash flow | 25,547 | 34,523 |
| Ratio | FY25 | FY26 |
|---|---|---|
| Growth | ||
| Net premium growth YoY | — | 18.9 |
| Profit growth YoY | — | 2.4 |
| Profitability & efficiency | ||
| Net margin % | 2.1 | 2.2 |
| Expense ratio % | 9.7 | 10.6 |
| Benefits / premium % | 58.2 | 54.3 |
| Return on equity % | 14.2 | 13.7 |